This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Elser, M. Articles by Hottiger, M. O. Search for Related Content PubMed PubMed Citation Articles by Elser, M. Articles by Hottiger, M. O.

---

Signaling and Regulation

Poly(ADP-Ribose) Polymerase 1 Promotes Tumor Cell Survival by Coactivating Hypoxia-Inducible Factor-1–Dependent Gene Expression

¹ Institute of Veterinary Biochemistry and Molecular Biology, ² Zurich Center for Integrative Human Physiology (ZIHP) and Institute of Physiology, and ³ Zurich Center for Integrative Human Physiology (ZIHP) and Institute of Veterinary Physiology, University of Zurich, Zurich, Switzerland; and ⁴ Gene Expression Unit, European Molecular Biology Laboratory (EMBL), Heidelberg, Germany

Requests for reprints: Michael O. Hottiger, Institute of Veterinary Biochemistry and Molecular Biology, University of Zurich, Winterthurerstrasse 190, 8057 Zurich, Switzerland. Phone: 41-44-635-54-74; Fax: 41-44-635-68-40. E-mail: hottiger{at}vetbio.uzh.ch

Hypoxia-inducible factor 1 (HIF-1) is the key transcription factor regulating hypoxia-dependent gene expression. Lack of oxygen stabilizes HIF-1, which in turn modulates the gene expression pattern to adapt cells to the hypoxic environment. Activation of HIF-1 is also detected in most solid tumors and supports tumor growth through the expression of target genes that are involved in processes like cell proliferation, energy metabolism, and oxygen delivery. Poly(ADP-ribose) polymerase 1 (PARP1) is a chromatin-associated protein, which was shown to regulate transcription. Here we report that chronic myelogenous leukemia cells expressing small interfering RNA against PARP1, which were injected into wild-type mice expressing PARP1, showed tumor growth with increased levels of necrosis, limited vascularization, and reduced expression of GLUT-1. Of note, PARP1-deficient cells showed a reduced HIF-1 transcriptional activation that was dependent on PARP1 enzymatic activity. PARP1 neither influenced binding of HIF-1 to its hypoxic response element nor changed HIF-1 protein levels in hypoxic cells. However, PARP1 formed a complex with HIF-1 through direct protein interaction and coactivated HIF-1–dependent gene expression. These findings provide convincing evidence that wild-type mice expressing PARP1 cannot compensate for the loss of PARP1 in tumor cells and strengthen the importance of the role of PARP1 as a transcriptional coactivator of HIF-1–dependent gene expression during tumor progression. (Mol Cancer Res 2008;6(2):282–90)